Search For "rand"
'Almost 1.5 lakh people tested for COVID-19 in India per day': AIIMS Direc
Updated : 5 years, 11 months ago IST
New Delhi [India], June 12 (ANI): Almost 1.5 lakh people are being tested for COVID-19 per day in the country and the number is going up each day, All India Institute of Medical Sciences (AIIMS), New Delhi, Director Dr Randeep Guleria said on Friday.
Read More
India having less number of COVID-19 cases per million population: Dr Rand
Updated : 5 years, 11 months ago IST
New Delhi [India], June 12 (ANI): India is having "very low" number of COVID-19 cases in terms of cases per million population as compared to other countries, said Dr Randeep Guleria, Director of Delhi's All India Institute of Medical Sciences (AIIMS), on Friday.
Read More
Rajasthan legislators will give you befitting reply by decisively defeatin
Updated : 5 years, 11 months ago IST
Jaipur (Rajasthan) [India], June 12 (ANI): Congress leader Randeep Singh Surjewala on Friday slammed the BJP and said that the people of Rajasthan and the legislators in the state will give the party a "befitting reply" in the forthcoming Rajya Sabha elections.
Read More
Community transmission of COVID-19 in Delhi, waiting for Centre to declare
Updated : 5 years, 11 months ago IST
New Delhi [India], June 9 (ANI): Delhi Health Minister Satyendar Jain on Tuesday said that AIIMS Director Dr Randeep Guleria has accepted that there is community transmission in the national capital but it is up to the Centre to make a declaration about it.
Read More
Plea for allowing rapid and random testing for prevention of COVID-19 spre
Updated : 5 years, 11 months ago IST
New Delhi [India], June 6 (ANI): A PIL has been filed in the Delhi High Court seeking direction to the government in the national capital to conduct rapid and random testing of any person showing any COVID-19 symptom.
Read More
Haryana CM, Congress Leader Surjewala engage in war of words
Updated : 5 years, 11 months ago IST
Kaithal (Haryana) [India], June 1 (ANI): Haryana Chief Minister Manohar Lal Khattar and Congress leader Randeep Singh Surjewala on Monday got into the war of words.
Read More
Surjewala slams Haryana CM over repeated attacks on woman IAS officer
Updated : 5 years, 11 months ago IST
New Delhi [India], June 1 (ANI): Congress leader Randeep Singh Surjewala on Sunday slammed Haryana Chief Minister Manohar Lal Khattar over the incidents of repeated attacks on a woman IAS officer.
Read More
Middle class in economic grief, reduction of interest rates brainless: Sur
Updated : 5 years, 12 months ago IST
New Delhi [India], May 29 (ANI): Congress leader Randeep Singh Surjewala on Friday said that the people belonging to the middle class and lower middle class are in economic grief and added that the decision to reduce the interest rates and discontinue the RBI Bonds during the coronavirus loc
Read More
Loves idea of holding hands, peck on forehead, unexpected messages: 'Old s
Updated : 5 years, 12 months ago IST
New Delhi [India], May 29 (ANI): Actor Kriti Sanon on Friday shared a beautiful monochrome picture of herself with a caption that stood out and reveals more about her inner personality and how she is as a person.
Read More
Lancet study is not randomised clinical trial, only analysis of hospital r
Updated : 5 years, 12 months ago IST
New Delhi [India], May 27 (ANI): Dismissing the reports of health risks from Hydroxychloroquine (HCQ) as per simmering reports cited by the World Health Organisation (WHO), Shekher Mande, Director General of the Council of Scientific and Industrial Research (CSIR), India, said on Wednesday t
Read More
Hydroxychloroquine poses little risk when administered alone in mild cases
Updated : 5 years, 12 months ago IST
New Delhi [India], May 26 (ANI): Dr Randeep Guleria, Director, All India Institute of Medical Sciences (AIIMS), New Delhi, on Tuesday said that 'judicious, and appropriate' use of hydroxychloroquine (HCQ) as a standalone drug should not pose any health risks in COVID-19 cases.
Read More
Glenmark to start new phase 3 clinical trial for hospitalised patients of
Updated : 5 years, 12 months ago IST
Mumbai (Maharashtra) [India], May 26 (ANI): Glenmark Pharmaceuticals on Tuesday announced a new randomised, open-label study to test the combined efficacy of two antiviral drugs Favipiravir and Umifenovir as a potential Covid-19 treatment strategy.
Read More